Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Kendrick Shunk, MD
Description
Summary
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Kendrick Shunk, MD
Professor, Medicine, School of Medicine. Authored (or co-authored) 82 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Cardiovascular Systems Inc
- ID
- NCT03108456
- Study Type
- Interventional
- Participants
- Expecting 2000 study participants
- Last Updated